Nearly 1 in 5 patients over 65 have Mild Cognitive Impairment and 1 in 9 have Dementia. With baby boomers advancing into older age, it’s more important than ever for PCPs to get ahead of their patients' cognitive health. But until better medications are available, is there a reason to screen, and can screening be more practical for PCPs?
Hear from an expert panel on the value of cognitive assessments in primary care, including:
● The science of neuroplasticity and implications for cognitive care
● Emerging evidence on modifiable risk factors & opportunities for prevention
● Strategies for adopting digital assessments in primary care